Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme
Author(s) -
Mona Loutfy,
Esteban Ribera,
Éric Florence,
Stéphane De Wit,
Antonella Castagna,
Robert J. Ryan,
Andrew Hill,
Hilde Vanaken,
Yvon van Delft,
Stephan Marks
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp366
Subject(s) - valaciclovir , aciclovir , medicine , etravirine , enfuvirtide , pharmacokinetics , penciclovir , pharmacology , human immunodeficiency virus (hiv) , virology , viral load , viral disease , herpesviridae , immunology , virus , antiretroviral therapy , herpes simplex virus , antigen , gp41 , epitope
SCOPUS: le.jinfo:eu-repo/semantics/publishe
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom